Physician profile
Kasee A Bates
NPI 1790235851
$1,182.02
in general payments reported to CMS, 2019-2025
16 companies · $336 in 2025
The $336 reported for 2025 was more than what a typical Psychiatric/Mental Health (Clinical Nurse Specialist) provider received nationally (typical 2025 total: $244).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $333 · 2022: $120 · 2023: $38.08 · 2024: $355 · 2025: $336.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $729.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $729.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $133.61 | 2024-2025 | Zepbound, Mounjaro |
| Novo Nordisk INC | $129.22 | 2024-2025 | Wegovy |
| Abbvie INC. | $122.64 | 2021-2025 | |
| Axsome Therapeutics, INC. | $122.16 | 2024 | Auvelity |
| Mannkind Corporation | $119.79 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $90.89 | 2024-2025 | Rexulti |
| Antares Pharma, INC. | $88.76 | 2021-2025 | Xyosted |
| Biohaven Pharmaceuticals, INC. | $62.95 | 2021 | |
| Clarus Therapeutics INC. | $61.06 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $55.98 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $54.66 | 2021-2024 | Xifaxan |
| Astrazeneca Pharmaceuticals LP | $43.90 | 2023-2025 | Farxiga, Airsupra |
| Exact Sciences Corporation | $36.24 | 2024-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Alkermes, INC. | $28.47 | 2025 | Vivitrol |
| Glaxosmithkline, LLC. | $17.00 | 2025 | Trelegy Ellipta |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $14.69 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kasee Bates listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.